Status:
COMPLETED
Clinical Validation of a Novel, Accelerometer Based, Continuous Respiratory Rate Sensor
Lead Sponsor:
Eupnea AS
Collaborating Sponsors:
Haraldsplass Deaconess Hospital
Conditions:
Respiratory Rate Accuracy Test
Capnography
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Comparing a wireless accelerometer-based sensor that continuously measure breathing rate with the gold standard capnography. The aim is to evaluate if both methods are equivalent.
Eligibility Criteria
Inclusion
- Admitted to the Hospital
- Expected to remain undisturbed for at least one hour
Exclusion
- Not able to give informed consent
- Use of high flow oxygen therapy
- Skin disease preventing proper attachment of the sensor
- Implanted electronic medical device.
- Known infection or colonisation with microbes necessitating protective measures above routine care
Key Trial Info
Start Date :
May 16 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 10 2025
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT06911541
Start Date
May 16 2025
End Date
August 10 2025
Last Update
August 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haraldsplass Deaconess Hospital
Bergen, Norway, 5021